将人类纤维细胞 (hFB) 的基因编辑和重编程转化为人类多能干细胞 (hiPSC)
Zhe Zhang1,2, Shinghua Ding1,2
1Department of Chemical and Biomedical Engineering (ChBME), University of Missouri, Columbia, MO, USA.
Neuromethods
|December 18, 2025
概括
研究人员开发了一种方法来创建同源的人类诱导多能干细胞 (hiPSCs),用于准确的疾病建模. 这种方法使用CRISPR/Cas9基因编辑和仙台病毒载体,克服动物模型的局限性和hiPSCs的可变遗传背景.
科学领域:
- 生物技术是生物技术.
- 基因组医学是基因组医学.
- 干细胞研究 干细胞研究
背景情况:
- 动物模型提供了洞察力,但由于特定物种的基因组差异,通常无法捕捉人类疾病表型.
- 人类诱导的多能干细胞 (hiPSCs) 对疾病建模和细胞疗法具有前景,因为它们与胚胎干细胞的相似性.
- 使用hiPSCs建模人类疾病需要同源控制来解释个体之间的遗传变异性.
研究的目的:
- 建立一种产生同位素人体纤维细胞 (hFB) 的方法,随后将其重新编程为hiPSC.
- 为疾病建模创建多个同位素hiPSC线路提供可靠的协议.
- 通过利用基因匹配的对照来克服现有疾病模型的局限性.
主要方法:
- 使用CRISPR/Cas9基因编辑来修改人类纤维细胞 (hFBs).
- 修改后的hFB被重新编程成诱导多能干细胞 (iPSC),使用仙台病毒载体.
- 该协议促进了多个同位素hiPSC线的生成.
主要成果:
- 使用CRISPR/Cas9.9成功生成同源的hFBs.
- 将同源hFB重新编程为同源hiPSC.
- 建立一个结构化的协议,以获得多个同位素hiPSC线路.
结论:
- 描述的方法可以生成同位基hiPSC线,这对于精确的人类疾病建模至关重要.
- 该协议解决了在病理学研究中对遗传控制细胞模型的需求.
- 该方法通过提供异构性hiPSC线路,促进了各种人类疾病的研究.
相关概念视频
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K


